I Ilhan1, A Cila, M Büyükpamukçu
1Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara.
Intrathecal methotrexate, used to treat non-Hodgkin's lymphoma, can cause severe central nervous system damage, including leukoencephalopathy, as seen in a pediatric patient. This case highlights the critical need for monitoring adverse effects of chemotherapy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: